Kerstin Pino Tossi

Kerstin Pino Tossi currently serves as VP and Head of Business Development at Thermosome GmbH since September 2022. Prior to this role, Kerstin was the Director of Business Development at Medigene AG from August 2014 to August 2022, where responsibilities included out-licensing immunotherapy programs, in-licensing new technologies, and representing the company at BD conferences. Notable achievements during this tenure include facilitating a research collaboration and asset purchase between Medigene and BioNTech, and establishing partnerships with IRICoR and Université de Montréal, as well as Roivant for cellular therapies. Earlier experience at Medigene AG also included the role of Business Development Manager, where Kerstin was part of the execution team for a strategic alliance with bluebird bio and out-licensed technology to 2A Pharma AB. Kerstin's career began at Medigene AG as a Senior Scientist and Project Coordinator, overseeing preclinical models and external collaborations. Educational background includes a Ph.D. in Biology from Ludwig-Maximilians-Universität München.